"Seeing the Big Picture: Real World Treatment Strategies for Dry AMD" presented by Dr. Jaycob Avaylon

 

Learning Objectives: 

  • Describe study data for safety and efficacy of photobiomodulation.
  • Assess real-world outcomes for complement inhibitors in treatment of geographic atrophy.
  • Evaluate cost-benefit analysis for treatment options in Dry AMD

Pre-presentation questions:

  1. At 24 months, photobiomodulation treatment is associated with: 
    1. Small improvements
    2. No change in volume of macular drusen
    3. Increased macular neovascularization
    4. Alll of the above
  2. What is the risk of developing macular neovascularization with complement inhibitor treatment?
    1. 2%
    2. 5%
    3. 12%
    4. None of the above
  3. How much does photobiomodulation cost?
    1. $500
    2. $1000
    3. $2500
    4. $2500 every 4-6 months
    5. $2500 every 4-6 months out of pocket
Session date: 
04/17/2026 - 8:30am EDT to 06/18/2026 - 10:59am EDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation
    UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
Please login or register to take this course.
Faculty List: 
Planner(s)

Claire Fraser

has no relevant financial relationships to disclose at this time.
Speaker(s)

Jaycob Avaylon, MD

has no relevant financial relationships to disclose at this time.